fda approval of tirzepatide for weight loss Grants a New Indication Obesity Management Eli Lilly's weight-loss pill is

What the clinical evidence shows The landmark Phase 2 trial by Teichman et al

in @Diagnostics_MDPI: doi.org/10.3390/diagno #Obesity #GLP1 #GIP #Semaglutide #Diagnostics Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide

Expect nausea, bloating, and shifts in bowel habits during dose escalation

Tune in to hear Suzy Badaracco, president of Culinary Tides, and Sherry Frey, vice president, Total Wellness, NielsenIQ, in a conversation guided by Michael Costa, managing editor of Food Business News , as they highlight the effect GLP-1 medications are having on consumer packaged goods companies

DAMPs also impact Kupffer cells, activating the nucleotide-binding oligomerization domain-like receptor (NLR) Family, Pyrin Domain-Containing 3 protein (NLRP3), a type of inflammasome leading to IL-1 secretion and inflammation, and pyroptosis, releasing more DAMPs and perpetuating a destructive cycle (Hammerich and Tacke, 2023)